Meeting Patient Expectations Will Drive Pharmacy Forward | Asembia 2025
Drug Topics
APRIL 30, 2025
Through digital innovations, transparency, and accessibility, pharmacists can help meet patients where they are at to improve their health outcomes.
Wed.Apr 30, 2025
442 
Analysis Finds Children Have Elevated Kidney, Heart Risks Years After COVID-19 Infection
Pharmacy Times
APRIL 30, 2025
Research reveals that children face significant long-term health risks, including kidney, gastrointestinal, and cardiovascular issues, after COVID-19 infection.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
The Importance of Health Care Equity in Specialty Pharmacy | Asembia 2025
Drug Topics
APRIL 30, 2025
A conversation with Shawn Griffin, MD, FAAFP, President and CEO of URAC, at Asembias AXS25 Summit.
Is the FDA headed for a major reorganization?
PharmaVoice
APRIL 30, 2025
A leaked document revealed details about changes that could impact how the agency operates, but recent comments from FDA Commissioner Dr. Marty Makary have muddied the picture.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
How PBMs Gained Notoriety in the Prescription Drug Market
Drug Topics
APRIL 30, 2025
Expert on drug pricing and pharmacy benefits, Antonio Ciaccia joined Drug Topics to discuss how PBMs came to hold so much control of the pharmaceutical supply chain.
National Stress Awareness Month Is Here
Pharmacy Times
APRIL 30, 2025
Pharmacists can perform MTM consultations and provide clinical recommendations to the health care team.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Where to Start in Pharma Research: A Modern Guide for Marketers
Pharma Marketing Network
APRIL 30, 2025
Table of Contents Understanding the Pharma Research Landscape Leveraging Patient Influencers in Research Utilizing Digital Tools and Platforms Strategic Steps to Initiate Pharma Research Conclusion FAQs Understanding the Pharma Research Landscape Embarking on pharma research can seem daunting, especially with the industry’s rapid evolution. However, understanding the current landscape is crucial for effective marketing strategies.
Medicare Price Negotiations Pose Unintended Challenges for Pharmacy | Asembia 2025
Drug Topics
APRIL 30, 2025
Through communication and reform, pharmacies will be able to make changes in order to continue to provide the best care to patients.
Novartis grabs kidney drug developer Regulus in $1.7bn deal
pharmaphorum
APRIL 30, 2025
Novartis has grown in renal diseases once again with a $1.
PQA Presents Quality Awards to Eight Medicare Plan Contracts for High Achievement in Medication Quality Measures
Drug Topics
APRIL 30, 2025
Awards Honor Excellence and Improvement in Overall CMS Medicare Part D Star Ratings and PQA Medication Measures.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Asembia AXS25: Strategic Partnerships Driving Pharmaceutical Innovation
Pharmacy Times
APRIL 30, 2025
Specialty distributors provide strategic partnerships that enhance pharmaceutical manufacturers' ability to bring innovative medicines to market.
Pharmacist Support Is Key to Retinal Therapy Success | Asembia 2025
Drug Topics
APRIL 30, 2025
A conversation with Casey Koch, PharmD, MBA, BCACP, clinical pharmacy coordinator at SelectHealth, at Asembias AXS25 Summit.
AACR 2025: Continuous Subcutaneous Lenalidomide Shows Promise in Reducing Toxicity in R/R Multiple Myeloma
Pharmacy Times
APRIL 30, 2025
A phase 1b study demonstrated that continuous subcutaneous infusion of low-dose lenalidomide in patients with relapsed or refractory (R/R) multiple myeloma achieved promising efficacy with significantly reduced hematologic toxicity compared to conventional oral dosing.
Rising Demand, New Indications Put GLP-1s in the Spotlight | Asembia 2025
Drug Topics
APRIL 30, 2025
A conversation with Becky Davis, principal at Charles River Associates, at Asembias AXS25 Summit.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Driving innovation and improving patient outcomes through inclusive medical research
pharmaphorum
APRIL 30, 2025
Driving innovation and improving patient outcomes through inclusive medical research Nicole.
Regulatory Requirements and Credentialing for Pharmacy-Based Point-of-Care Testing
Drug Topics
APRIL 30, 2025
A panelist discusses how obtaining a Clinical Laboratory Improvement Amendments (CLIA) waiver is an essential regulatory step for pharmacies to perform point-of-care testing, followed by credentialing with payers to receive reimbursement for these services.
AACR 2025: AI-Driven Biomarker Model Can Accurately Detect Cancer Cachexia
Pharmacy Times
APRIL 30, 2025
Artificial intelligence (AI) models enhance cancer cachexia detection, improving accuracy in predicting muscle atrophy and patient outcomes through advanced biomarker analysis.
GSK "well positioned" to weather pharma tariffs
pharmaphorum
APRIL 30, 2025
GSK has said it is not too worried about the impact of potential pharma-specific US tariff rules as it posts a solid set of first-quarter results.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 30, 2025
A significant upside to the acquisition is the new-found ability for BetterHelp customers to use insurance coverage for mental health services, a barrier that has kept some customers from signing up with the cash-pay mental health provider.
Asembia 2025: How Specialty Pharmacies Are Evolving to Support Rare Conditions
Pharmaceutical Commerce
APRIL 30, 2025
Will Pih, co-founder, Two Labs, explains how specialty pharmacies and manufacturers are adapting to financial pressures in rare disease care through patient-centric services, hub innovation, and hybrid technology models.
AZ backs up threat of manufacturing shift from Europe
pharmaphorum
APRIL 30, 2025
AstraZeneca has said it is considering a shift in the production of some medicines from Europe to the US in order to sidestep potential tariffs
Asembia AXS25: Patients Desire Education and Thorough Resources to Better Navigate Health Plans
Pharmacy Times
APRIL 30, 2025
A panel of health care experts at Asembias AXS25 Summit discussed the critical need for improved patient education and resources to help navigate complex financial assistance programs and health care plans.
Novo Nordisk unleashes Wegovy telehealth blitz
pharmaphorum
APRIL 30, 2025
Novo Nordisk has enlisted the aid of major telehealth companies as it tries to dominate the self-pay market for obesity drugs in the US
Asembia AXS25: Transformative Challenges for Pharmacists, Providers Ahead as IRA Drug Negotiations Go Into Effect
Pharmacy Times
APRIL 30, 2025
The Inflation Reduction Act's (IRAs) drug negotiation provisions will fundamentally reshape Medicare drug pricing, provider reimbursement, and healthcare delivery dynamics across Part B and commercial markets, according to panelists at Asembias AXS25 Summit.
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 30, 2025
How do invisible design choices shape patient experiences? This week on "Podnosis," CannonDesigns Abbie Clary unpacks the role of human-centered design in advancing health equity.
From Mutation to Management: Risk Stratification, the Power of JAK Inhibition, and the Pharmacist’s Role
Pharmacy Times
APRIL 30, 2025
Explore the role of JAK inhibitors in myelofibrosis treatment, focusing on optimizing dosages and managing adverse effects for better patient outcomes.
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 30, 2025
UnitedHealth Group announced Tuesday that Patrick Conway would take the helm of its Optum division.
NCCN Flash Update: Changes to NCCN Guidelines for Breast Cancer Version 4.2025
Pharmacy Times
APRIL 30, 2025
Updates on April 30, 2025, introduce changes to treatment regimens, sequencing flexibility, febrile neutropenia risk assessments, and drug-specific safety and supportive care guidance.
Pfizer CEO thinks pharma tariffs won’t be applied equally
STAT
APRIL 30, 2025
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, let’s get into all the updates from a busy earnings season so far.
Precision Oncology in Focus: ctDNA's Role in Colon Cancer Management
Pharmacy Times
APRIL 30, 2025
Sasha Watson, PharmD, BCOP, discusses the emerging role of circulating tumor DNA (ctDNA) in colon cancer, highlighting its potential to enhance precision oncology by improving early detection, guiding adjuvant therapy decisions, and monitoring disease recurrence and treatment resistance.
FDA approves Abeona’s $3.1m cell therapy for rare skin disease
Pharmaceutical Technology
APRIL 30, 2025
Abeona has won FDA approval for Zevaskyn, setting up a commercial challenge to Krystal Biotech in the rare skin disease market.
Asembia AXS25: Leveraging Advanced Analytics and Data Insights to Improve Specialty Pharmacy Patient Outcomes
Pharmacy Times
APRIL 30, 2025
Specialty pharmacies can leverage advanced analytics, AI, and comprehensive data insights to create targeted clinical programs.
Abeona prices rare cell disorder gene therapy at $3.1m
pharmaphorum
APRIL 30, 2025
Abeona Therapeutics' Zevaskyn has been approved in the US as a treatment for the rare skin disorder recessive dystrophic epidermolysis bullosa (DEB)
Let's personalize your content